当前位置:首页 - 行情中心 - 沃森生物(300142) - 财务分析 - 现金流量表

沃森生物

(300142)

  

流通市值:174.89亿  总市值:179.77亿
流通股本:15.56亿   总股本:15.99亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,771,029,1941,140,953,138.4455,896,090.973,476,205,413.6
  收到的税费返还6,947,105.181,631,558.23-2,319,496.16
  收到其他与经营活动有关的现金72,075,640.8651,084,430.85,463,098.85119,205,826.04
  经营活动现金流入小计1,850,051,940.041,193,669,127.43461,359,189.823,597,730,735.8
  购买商品、接受劳务支付的现金1,338,841,211.27778,736,131.3457,915,823.661,844,648,011.24
  支付给职工以及为职工支付的现金272,877,806.58198,170,171.69125,212,059.95454,811,257.82
  支付的各项税费97,197,320.0256,667,782.4323,612,414139,135,975.18
  支付其他与经营活动有关的现金61,443,512.4143,437,957.6616,293,815.05122,610,964.06
  经营活动现金流出小计1,770,359,850.281,077,012,043.08623,034,112.662,561,206,208.3
  经营活动产生的现金流量净额79,692,089.76116,657,084.35-161,674,922.841,036,524,527.5
二、投资活动产生的现金流量:
  收回投资收到的现金158,285,591.07---
  取得投资收益收到的现金3,444,383.94--4,895,829.01
  处置固定资产、无形资产和其他长期资产收回的现金净额192,715191,389827,624466,978.5
  投资活动现金流入小计161,922,690.01191,389827,6245,362,807.51
  购建固定资产、无形资产和其他长期资产支付的现金357,253,150.1141,478,824.7170,445,611.45550,029,878.5
  投资支付的现金---22,000,000
  支付其他与投资活动有关的现金---700,000,000
  投资活动现金流出小计357,253,150.1141,478,824.7170,445,611.451,272,029,878.5
  投资活动产生的现金流量净额-195,330,460.09-141,287,435.71-69,617,987.45-1,266,667,070.99
三、筹资活动产生的现金流量:
  吸收投资收到的现金2,440,0002,440,000--
  其中:子公司吸收少数股东投资收到的现金2,440,0002,440,000--
  取得借款收到的现金---38,216,439.2
  收到其他与筹资活动有关的现金---182,576.95
  筹资活动现金流入平衡项目00-0
  筹资活动现金流入小计2,440,0002,440,000-38,399,016.15
  偿还债务支付的现金232,993,145.4424,510,00020,000,000329,580,000
  分配股利、利润或偿付利息支付的现金788,889,566.3434,172,909.884,268,386.0940,940,003.26
  其中:子公司支付给少数股东的股利、利润760,868,500409,731,500--
  支付其他与筹资活动有关的现金947,982,701.17745,691,685.763,084,13538,909,655.31
  筹资活动现金流出小计1,969,865,412.911,204,374,595.6427,352,521.09409,429,658.57
  筹资活动产生的现金流量净额-1,967,425,412.91-1,201,934,595.64-27,352,521.09-371,030,642.42
四、汇率变动对现金及现金等价物的影响908,358.771,233,445.5419,876.895,413,290.34
五、现金及现金等价物净增加额-2,082,155,424.47-1,225,331,501.46-258,625,554.49-595,759,895.57
  加:期初现金及现金等价物余额3,759,102,816.013,759,102,816.013,759,102,816.014,354,862,711.58
  期末现金及现金等价物余额1,676,947,391.542,533,771,314.553,500,477,261.523,759,102,816.01
补充资料:
  净利润--7,094,241.99-174,397,875.24
  资产减值准备-192,719,154.7-157,082,365.91
  固定资产和投资性房地产折旧-131,884,394.83-248,717,522
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-131,884,394.83-248,717,522
  无形资产摊销-63,213,823.7-114,875,013.27
  长期待摊费用摊销-9,993,117.25-23,020,888.53
  处置固定资产、无形资产和其他长期资产的损失--130,387.03-1,767,057.21
  固定资产报废损失-602,963.92-967,178.5
  公允价值变动损失--13,422,300-98,339,100
  财务费用--8,569,362.17--7,743,187.6
  投资损失-486,057.34--5,025,931.85
  递延所得税--7,437,726.37--5,815,718.72
  其中:递延所得税资产减少-1,557,420.75--1,112,955.95
    递延所得税负债增加--8,995,147.12--4,702,762.77
  存货的减少-78,348,276.39-115,879,650.96
  经营性应收项目的减少--28,432,302.07-781,300,754.09
  经营性应付项目的增加--301,465,399.82--686,189,884.35
  现金的期末余额-2,533,771,314.55-3,759,102,816.01
  减:现金的期初余额-3,759,102,816.01-4,354,862,711.58
  现金及现金等价物的净增加额--1,225,331,501.46--595,759,895.57
公告日期2025-10-292025-08-262025-04-262025-04-12
审计意见(境内)标准无保留意见
TOP↑